Mabion SA

Research Mabion SA (272) on Bullrun: market cap EUR 27.99M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker272
• ExchangeF
• CountryPoland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 27.99M
• Financial periodQ3 2025
• RevenueEUR 4.08M
• Net income-EUR 10.75M
• Free cash flow-EUR 5.92M
• Gross margin-80.9%

Valuation Snapshot

latest market cap is EUR 27.99M.

About Mabion SA

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services.

Frequently asked questions

What is Mabion SA's market cap?

Mabion SA's market capitalization is EUR 27.99M.

What does Mabion SA do?

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.